A blood test developed by researchers in Australia and Japan appears to be able to predict the risk of developing Alzheimer’s Disease, with 90% accuracy. Detection of amyloid beta in the blood may be taken as a biomarker for levels of amyloid beta in the brain, it appears, although further trials are required.
“Experts said the approach was at an early stage and needed further testing”.
Gallagher, J. (2018). Blood test finds toxic Alzheimer’s proteins. London: BBC Health News, January 31st 2018.
This relates to:
Full Text Link (Note: This article may be available freely for a limited time. It would normally require a suitable Athens password, a journal subscription or payment for access).
Nakamura, A. Kaneko, N. [and] Villemagne, VL. [et al] (2018). High performance plasma amyloid-β biomarkers for Alzheimer’s disease. [Letter]. Nature. [Epub ahead of print].